Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Rennert

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
EMBO Reports|January 14, 2003
NF-kappaB activation by protein kinase C isoforms and B-cell functionJorge Moscat, María T Diaz-Meco, Paul Rennert
Annual Review of Immunology|November 13, 2002
BAFF AND APRIL: a tutorial on B cell survivalFabienne Mackay, Pascal Schneider, Paul Rennert, et al.
Cells|January 21, 2023
A CD19-Anti-ErbB2 scFv Engager Protein Enables CD19-Specific CAR T Cells to Eradicate ErbB2<sup>+</sup> Solid CancerAndreas A Hombach, Christine Ambrose, Roy Lobb, et al.
Virology Journal|February 4, 2016
Gene expression profiling of rubella virus infected primary endothelial cells of fetal and adult originHenriette Geyer, Michael Bauer, Jennifer Neumann, et al.
The EMBO Journal|July 30, 2002
Role of zeta PKC in B-cell signaling and functionPilar Martin, Angeles Duran, Susana Minguet, et al.
Endocrinology|June 24, 2006
Treatment of autoimmune hyperthyroidism in a murine model of Graves' disease with tumor necrosis factor-family ligand inhibitors suggests a key role for B cell activating factor in disease pathologyJacqueline A Gilbert, Susan L Kalled, Jane Moorhead, et al.
Journal of Virology|June 30, 2017
Mumps Virus SH Protein Inhibits NF-κB Activation by Interacting with Tumor Necrosis Factor Receptor 1, Interleukin-1 Receptor 1, and Toll-Like Receptor 3 ComplexesStephanie Franz, Paul Rennert, Maria Woznik, et al.
Glycobiology|January 6, 2021
Glyco-engineered HEK 293-F cell lines for the production of therapeutic glycoproteins with human N-glycosylation and improved pharmacokineticsRico Uhler, Ruth Popa-Wagner, Mario Kröning, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2005
Control of T helper 2 cell function and allergic airway inflammation by PKCzetaPilar Martin, Ricardo Villares, Sandra Rodriguez-Mascarenhas, et al.
Immunity|April 8, 2014
TIM-1 glycoprotein binds the adhesion receptor P-selectin and mediates T cell trafficking during inflammation and autoimmunityStefano Angiari, Tiziano Donnarumma, Barbara Rossi, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
EMBO Reports|January 14, 2003
NF-kappaB activation by protein kinase C isoforms and B-cell functionJorge Moscat, María T Diaz-Meco, Paul Rennert
Annual Review of Immunology|November 13, 2002
BAFF AND APRIL: a tutorial on B cell survivalFabienne Mackay, Pascal Schneider, Paul Rennert, et al.
Cells|January 21, 2023
A CD19-Anti-ErbB2 scFv Engager Protein Enables CD19-Specific CAR T Cells to Eradicate ErbB2<sup>+</sup> Solid CancerAndreas A Hombach, Christine Ambrose, Roy Lobb, et al.
Virology Journal|February 4, 2016
Gene expression profiling of rubella virus infected primary endothelial cells of fetal and adult originHenriette Geyer, Michael Bauer, Jennifer Neumann, et al.
The EMBO Journal|July 30, 2002
Role of zeta PKC in B-cell signaling and functionPilar Martin, Angeles Duran, Susana Minguet, et al.
Endocrinology|June 24, 2006
Treatment of autoimmune hyperthyroidism in a murine model of Graves' disease with tumor necrosis factor-family ligand inhibitors suggests a key role for B cell activating factor in disease pathologyJacqueline A Gilbert, Susan L Kalled, Jane Moorhead, et al.
Journal of Virology|June 30, 2017
Mumps Virus SH Protein Inhibits NF-κB Activation by Interacting with Tumor Necrosis Factor Receptor 1, Interleukin-1 Receptor 1, and Toll-Like Receptor 3 ComplexesStephanie Franz, Paul Rennert, Maria Woznik, et al.
Glycobiology|January 6, 2021
Glyco-engineered HEK 293-F cell lines for the production of therapeutic glycoproteins with human N-glycosylation and improved pharmacokineticsRico Uhler, Ruth Popa-Wagner, Mario Kröning, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2005
Control of T helper 2 cell function and allergic airway inflammation by PKCzetaPilar Martin, Ricardo Villares, Sandra Rodriguez-Mascarenhas, et al.
Immunity|April 8, 2014
TIM-1 glycoprotein binds the adhesion receptor P-selectin and mediates T cell trafficking during inflammation and autoimmunityStefano Angiari, Tiziano Donnarumma, Barbara Rossi, et al.
Pageof 2